These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27133951)

  • 1. Is preoperative anemia a risk factor for upper tract urothelial carcinoma following radical nephroureterectomy?
    Yeh HC; Chien TM; Wu WJ; Li CC; Li WM; Ke HL; Chou YH; Wang CJ; Huang SP; Li CF; Liang PI; Huang CN
    Urol Oncol; 2016 Aug; 34(8):337.e1-9. PubMed ID: 27133951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Rink M; Sharifi N; Fritsche HM; Aziz A; Miller F; Kluth LA; Ngamsri T; Dahlem R; Chun FK; Shariat SF; Stenzl A; Fisch M; Gakis G
    J Urol; 2014 Feb; 191(2):316-22. PubMed ID: 24036235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluating the impact of preoperative anemia on the prognosis of upper tract urothelial carcinoma following radical nephroureterectomy: A single-center retrospective study of 686 patients].
    Guan B; Weng M; Fan H; Peng D; Fang D; Xiong GY; Li XS; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):1056-1061. PubMed ID: 31848504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of preoperative anemia on upper tract urothelial carcinoma.
    Tan P; Xie N; Liao H; Zou L; Xu H; Yang L; Liu L; Wei Q
    Medicine (Baltimore); 2018 Sep; 97(37):e12300. PubMed ID: 30212968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of Preoperative Anemia on Urothelial and Extraurothelial Recurrence in Patients With Upper Tract Urothelial Carcinoma.
    Milojevic B; Dzamic Z; Kajmakovic B; Durutovic O; Bumbasirevic U; Sipetic Grujicic S
    Clin Genitourin Cancer; 2015 Oct; 13(5):485-91. PubMed ID: 25920995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
    Rink M; Soave A; Dahlem R; Aziz A; Al-Sayed F; Peine S; Engel O; Kluth LA; Stenzl A; Burger M; Shariat SF; Fisch M; Fritsche HM; Gakis G
    Clin Genitourin Cancer; 2016 Feb; 14(1):96-104. PubMed ID: 26506908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De Ritis Ratio (AST/ALT) as a Significant Prognostic Factor in Patients With Upper Tract Urothelial Cancer Treated With Surgery.
    Lee H; Choi YH; Sung HH; Han DH; Jeon HG; Chang Jeong B; Seo SI; Jeon SS; Lee HM; Choi HY
    Clin Genitourin Cancer; 2017 Jun; 15(3):e379-e385. PubMed ID: 27692696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.
    Shibing Y; Turun S; Qiang W; Junhao L; Haichao Y; Shengqiang Q; Ping H; Dehong C
    Urol Oncol; 2015 May; 33(5):204.e9-16. PubMed ID: 25800374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Lymphovascular Invasion in Node-Negative Upper Urinary Tract Urothelial Carcinoma Patients Undergoing Radical Nephroureterectomy.
    Liu W; Zhou Z; Dong D; Sun L; Zhang G
    Yonsei Med J; 2019 Feb; 60(2):174-181. PubMed ID: 30666839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum pre-albumin as an independent prognostic indicator in patients with localized upper tract urothelial carcinoma after radical nephroureterectomy.
    Huang J; Wang Y; Yuan Y; Chen Y; Kong W; Chen H; Zhang J; Huang Y
    Oncotarget; 2017 May; 8(22):36772-36779. PubMed ID: 27906675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of tumor multifocality on outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy: A cohort study.
    Milojevic B; Bumbasirevic U; Santric V; Kajmakovic B; Dragicevic D; Radisavcevic D; Sretenovic M; Grujicic SS
    Curr Probl Cancer; 2021 Dec; 45(6):100747. PubMed ID: 33883080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of renal function for upper tract urothelial carcinoma who underwent radical nephroureterectomy: Sex differences.
    Chien TM; Li CC; Lu YM; Chang HW; Chou YH; Wu WJ
    J Formos Med Assoc; 2022 Nov; 121(11):2182-2190. PubMed ID: 35370029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence.
    Lee HY; Yeh HC; Wu WJ; He JS; Huang CN; Ke HL; Li WM; Li CF; Li CC
    World J Surg Oncol; 2018 Jul; 16(1):135. PubMed ID: 29986730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative positive voided urine cytology predicts poor clinical outcomes in patients with upper tract urothelial carcinoma undergoing nephroureterectomy.
    Liu W; Wang Z; Liu S; Yao Y; Liu Y; Zhang G
    BMC Cancer; 2020 Nov; 20(1):1113. PubMed ID: 33198698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma.
    Foerster B; Moschini M; Abufaraj M; Soria F; Gust KM; Rouprêt M; Karakiewicz PI; Briganti A; Rink M; Kluth L; Mathieu R; Margulis V; Lotan Y; Aziz A; John H; Shariat SF;
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1039-e1045. PubMed ID: 28694147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative prognostic nutritional index is a significant predictor of survival in patients with localized upper tract urothelial carcinoma after radical nephroureterectomy.
    Huang J; Yuan Y; Wang Y; Chen Y; Kong W; Xue W; Chen H; Zhang J; Huang Y
    Urol Oncol; 2017 Dec; 35(12):671.e1-671.e9. PubMed ID: 28826702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.
    Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M
    Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative predictive model and nomogram for disease recurrence following radical nephroureterectomy for high grade upper tract urothelial carcinoma.
    Freifeld Y; Ghandour R; Singla N; Woldu S; Clinton T; Kulangara R; Bagrodia A; Matin SF; Petros FG; Raman JD; Robyak H; Yan J; Zhu H; Rapoport L; Lotan Y; Margulis V
    Urol Oncol; 2019 Oct; 37(10):758-764. PubMed ID: 31378586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
    Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.